Page last updated: 2024-08-24

carbenoxolone sodium and Dermatitis Medicamentosa

carbenoxolone sodium has been researched along with Dermatitis Medicamentosa in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Elias, PM; Holleran, WM; Hupe, M; Mauro, T; Tiganescu, A; Uchida, Y	1

Other Studies

1 other study(ies) available for carbenoxolone sodium and Dermatitis Medicamentosa

Article	Year
Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice. Endocrinology, 2018, 01-01, Volume: 159, Issue:1 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Administration, Topical; Animals; Anti-Inflammatory Agents; Carbenoxolone; Corticosterone; Cytokines; Drug Eruptions; Enzyme Inhibitors; Epidermis; Extracellular Matrix; Female; Gene Expression Profiling; Gene Expression Regulation; Glucocorticoids; Granulation Tissue; Mice, Hairless; Organ Size; Skin; Wound Healing	2018

Article

Year

Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.

Endocrinology, 2018, 01-01, Volume: 159, Issue:1

Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Administration, Topical; Animals; Anti-Inflammatory Agents; Carbenoxolone; Corticosterone; Cytokines; Drug Eruptions; Enzyme Inhibitors; Epidermis; Extracellular Matrix; Female; Gene Expression Profiling; Gene Expression Regulation; Glucocorticoids; Granulation Tissue; Mice, Hairless; Organ Size; Skin; Wound Healing

2018